Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum - PubMed (original) (raw)
Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum
H Slawik et al. Neurochem Int. 2004 Oct.
Abstract
Prostaglandins (PG) are produced by the enzymatic activity of cyclooxygenase (COX). PGs and COX have been implicated in the pathophysiology of excitotoxicity and neurodegeneration in the central nervous system (CNS). The PGE2 receptor EP3 is the most abundantly expressed PGE2 receptor subtype in the brain. So far, in the innate rat brain EP3 receptors have been found exclusively in neurons. The aim of this study was to investigate whether EP3 expression in the brain changes under neurodegenerative circumstances such as an acute excitotoxic lesion. Intrastriatal injection of quinolinic acid (QUIN) resulted in a loss of EP3-positive striatal neurons, while simultaneously small glial-shaped EP3-positive cells appeared. Five days after lesioning, 63% of the glial-shaped EP3-positive cells could be identified as ED-1 expressing microglial cells. This percentage increased to 82% after 10 days, suggesting that most of the EP3-positive ED-1-negative cells on day 5 may be microglia which did not yet express ED-1. ED-1-positive microglia also expressed COX-1. These experiments show for the first time that activated microglial cells in excitotoxic lesions express in vivo the PGE2 receptor EP3 and the PGE2 synthesizing enzyme COX-1. Activation of EP3 receptor downregulates cAMP formation and may counteract the upregulation of cAMP formation via EP2 receptors, which has been linked to the anti-inflammatory effects of PGs. This change in EP3-receptor expression in microglia might participate in acute or chronic microglial activation in a variety of brain diseases such as ischemia or Alzheimer's disease (AD). Investigation of the expression of different PGE2 receptor subtypes might promote a better understanding of the pathophysiology of these diseases as well as leading to a modulation of microglial activation by a more specific interference with selective EP receptors than can be achieved by inhibiting global PG synthesis by selective or non-selective COX inhibitors.
Similar articles
- Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.
Caggiano AO, Kraig RP. Caggiano AO, et al. J Neurochem. 1999 Feb;72(2):565-75. doi: 10.1046/j.1471-4159.1999.0720565.x. J Neurochem. 1999. PMID: 9930728 Free PMC article. - Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
Arosh JA, Banu SK, Chapdelaine P, Fortier MA. Arosh JA, et al. Endocrinology. 2004 Jan;145(1):407-17. doi: 10.1210/en.2003-1007. Epub 2003 Sep 18. Endocrinology. 2004. PMID: 14500566 - Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K. McCullough L, et al. J Neurosci. 2004 Jan 7;24(1):257-68. doi: 10.1523/JNEUROSCI.4485-03.2004. J Neurosci. 2004. PMID: 14715958 Free PMC article. - Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions.
Levi G, Minghetti L, Aloisi F. Levi G, et al. Biochimie. 1998 Nov;80(11):899-904. doi: 10.1016/s0300-9084(00)88886-0. Biochimie. 1998. PMID: 9893949 Review. - [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
Hatae N. Hatae N. Yakugaku Zasshi. 2003 Oct;123(10):837-43. doi: 10.1248/yakushi.123.837. Yakugaku Zasshi. 2003. PMID: 14577329 Review. Japanese.
Cited by
- Effects of DISC1 on Alzheimer's disease cell models assessed by iTRAQ proteomics analysis.
Lu J, Huang R, Peng Y, Wang H, Feng Z, Fan Y, Zeng Z, Wang Y, Wei J, Wang Z. Lu J, et al. Biosci Rep. 2022 Jan 28;42(1):BSR20211150. doi: 10.1042/BSR20211150. Biosci Rep. 2022. PMID: 34981809 Free PMC article. - Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer's Disease.
Johansson JU, Woodling NS, Shi J, Andreasson KI. Johansson JU, et al. Curr Immunol Rev. 2015 Aug;11(2):125-131. doi: 10.2174/1573395511666150707181414. Curr Immunol Rev. 2015. PMID: 28413375 Free PMC article. - Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage.
Leclerc JL, Lampert AS, Diller MA, Doré S. Leclerc JL, et al. Eur J Neurosci. 2015 May;41(10):1381-91. doi: 10.1111/ejn.12909. Eur J Neurosci. 2015. PMID: 25847406 Free PMC article. - Neuroinflammatory processes in Alzheimer's disease.
Heneka MT, O'Banion MK, Terwel D, Kummer MP. Heneka MT, et al. J Neural Transm (Vienna). 2010 Aug;117(8):919-47. doi: 10.1007/s00702-010-0438-z. Epub 2010 Jul 15. J Neural Transm (Vienna). 2010. PMID: 20632195 Review. - Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF.
Hutchinson AJ, Chou CL, Israel DD, Xu W, Regan JW. Hutchinson AJ, et al. Neurochem Int. 2009 Jun;54(7):439-46. doi: 10.1016/j.neuint.2009.01.018. Epub 2009 Feb 6. Neurochem Int. 2009. PMID: 19428786 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources